Humana expands connectivity of its wellness program

Humana is expanding the connectivity of its health and wellness program, Go365, by partnering up with personal health data company Validic.

Members of Go365 will be able to connect hundreds of wearables, health apps and in-home medical devices to the program through the partnership. The connectivity means members can essentially bring their own device to the program.

Humana will gain increased insight into their members using the devices, and the program incentivizes members achieve their best health, such as participating in preventive health screenings and fitness activities, according to Humana.

It may also help Humana engage more members, as 35% of wearable owners today own a device manufactured outside the top five wearable vendors. The health insurer has already partnered with several big names in wearables, including Fitbit.

"We are proud to provide programs that support people in their journey to better health," Jeff Reid, senior vice president of Humana Wellness Solutions, said in a statement. "In broadening the accessibility of Go365––both in terms of connectivity and membership––we enable more people, including those with differing socioeconomic backgrounds or health challenges, to achieve better health in a premier wellness program."

Humana’s Go365 program has more than five million members nationwide. A recent study of a group of members found participants increased their consumption of healthier foods and exercise, with less tobacco use and stress.

Validic and Humana plan to expand their partnership down the line to include other health barriers, such as nutrition, smoking cessation, mental health and more, the two companies said.

"This collaboration is about focusing resources on populations that require more attention and giving support to individuals that need a continuous partner in their health,” Validic CEO Drew Schiller said in a statement. “The work between Humana and Validic is about empowering people with the tools and freedom to live better and healthier lives.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.